Fabrazyme® is approved in the 15 European Union countries and Iceland, Norway, Czech Republic, New Zealand, Australia, and Israel. This site contains information for healthcare professionals and is intended for use by physicians practicing in countries where Fabrazyme is approved.

			Please use your DocCheck user name and password to log-in. Username: Password:
		Get a free DocCheck password. Forgot your DocCheck password?